|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:GRB2-PCYT1A (FusionGDB2 ID:34521) |
Fusion Gene Summary for GRB2-PCYT1A |
Fusion gene summary |
Fusion gene information | Fusion gene name: GRB2-PCYT1A | Fusion gene ID: 34521 | Hgene | Tgene | Gene symbol | GRB2 | PCYT1A | Gene ID | 2885 | 5130 |
Gene name | growth factor receptor bound protein 2 | phosphate cytidylyltransferase 1, choline, alpha | |
Synonyms | ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2 | CCTA|CT|CTA|CTPCT|PCYT1|SMDCRD | |
Cytomap | 17q25.1 | 3q29 | |
Type of gene | protein-coding | protein-coding | |
Description | growth factor receptor-bound protein 2HT027SH2/SH3 adapter GRB2abundant SRC homologyepidermal growth factor receptor-binding protein GRB2epididymis secretory sperm binding proteingrowth factor receptor-bound protein 3protein Ash | choline-phosphate cytidylyltransferase ACCT ACCT-alphaCT ACTP:phosphocholine cytidylyltransferase Aphosphorylcholine transferase A | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | P62993 | . | |
Ensembl transtripts involved in fusion gene | ENST00000392562, ENST00000316804, ENST00000316615, ENST00000392563, ENST00000392564, ENST00000578961, ENST00000462266, | ENST00000419333, ENST00000292823, ENST00000431016, ENST00000491544, | |
Fusion gene scores | * DoF score | 18 X 13 X 11=2574 | 8 X 8 X 5=320 |
# samples | 25 | 9 | |
** MAII score | log2(25/2574*10)=-3.36401205355861 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/320*10)=-1.83007499855769 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: GRB2 [Title/Abstract] AND PCYT1A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | GRB2(73389632)-PCYT1A(195997412), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | GRB2-PCYT1A seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. GRB2-PCYT1A seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across GRB2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PCYT1A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-46-6025-01A | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
ChimerDB4 | LUSC | TCGA-46-6025 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
ChimerDB4 | LUSC | TCGA-46-6025 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
Top |
Fusion Gene ORF analysis for GRB2-PCYT1A |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000392562 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392562 | ENST00000292823 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392562 | ENST00000431016 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392562 | ENST00000491544 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
Frame-shift | ENST00000316804 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316804 | ENST00000292823 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316804 | ENST00000431016 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316804 | ENST00000491544 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
Frame-shift | ENST00000316615 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316615 | ENST00000292823 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316615 | ENST00000431016 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316615 | ENST00000491544 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
In-frame | ENST00000392563 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392563 | ENST00000292823 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392563 | ENST00000431016 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392563 | ENST00000491544 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
In-frame | ENST00000392564 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392564 | ENST00000292823 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392564 | ENST00000431016 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392564 | ENST00000491544 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
In-frame | ENST00000578961 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000578961 | ENST00000292823 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000578961 | ENST00000431016 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000578961 | ENST00000491544 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
intron-3CDS | ENST00000462266 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
intron-5UTR | ENST00000462266 | ENST00000292823 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
intron-5UTR | ENST00000462266 | ENST00000431016 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
intron-5UTR | ENST00000462266 | ENST00000491544 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - |
Frame-shift | ENST00000392562 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392562 | ENST00000292823 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392562 | ENST00000431016 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392562 | ENST00000491544 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
Frame-shift | ENST00000316804 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316804 | ENST00000292823 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316804 | ENST00000431016 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316804 | ENST00000491544 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
Frame-shift | ENST00000316615 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316615 | ENST00000292823 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316615 | ENST00000431016 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000316615 | ENST00000491544 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
In-frame | ENST00000392563 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392563 | ENST00000292823 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392563 | ENST00000431016 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392563 | ENST00000491544 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
In-frame | ENST00000392564 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392564 | ENST00000292823 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392564 | ENST00000431016 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000392564 | ENST00000491544 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
In-frame | ENST00000578961 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000578961 | ENST00000292823 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000578961 | ENST00000431016 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
5CDS-5UTR | ENST00000578961 | ENST00000491544 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
intron-3CDS | ENST00000462266 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
intron-5UTR | ENST00000462266 | ENST00000292823 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
intron-5UTR | ENST00000462266 | ENST00000431016 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
intron-5UTR | ENST00000462266 | ENST00000491544 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000392563 | GRB2 | chr17 | 73389632 | - | ENST00000419333 | PCYT1A | chr3 | 195997412 | - | 1431 | 106 | 116 | 1258 | 380 |
ENST00000392564 | GRB2 | chr17 | 73389632 | - | ENST00000419333 | PCYT1A | chr3 | 195997412 | - | 1639 | 314 | 324 | 1466 | 380 |
ENST00000578961 | GRB2 | chr17 | 73389632 | - | ENST00000419333 | PCYT1A | chr3 | 195997412 | - | 1578 | 253 | 263 | 1405 | 380 |
ENST00000392563 | GRB2 | chr17 | 73389631 | - | ENST00000419333 | PCYT1A | chr3 | 195997412 | - | 1431 | 106 | 116 | 1258 | 380 |
ENST00000392564 | GRB2 | chr17 | 73389631 | - | ENST00000419333 | PCYT1A | chr3 | 195997412 | - | 1639 | 314 | 324 | 1466 | 380 |
ENST00000578961 | GRB2 | chr17 | 73389631 | - | ENST00000419333 | PCYT1A | chr3 | 195997412 | - | 1578 | 253 | 263 | 1405 | 380 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000392563 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - | 0.007003486 | 0.9929965 |
ENST00000392564 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - | 0.006762638 | 0.9932374 |
ENST00000578961 | ENST00000419333 | GRB2 | chr17 | 73389632 | - | PCYT1A | chr3 | 195997412 | - | 0.007025976 | 0.99297404 |
ENST00000392563 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - | 0.007003486 | 0.9929965 |
ENST00000392564 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - | 0.006762638 | 0.9932374 |
ENST00000578961 | ENST00000419333 | GRB2 | chr17 | 73389631 | - | PCYT1A | chr3 | 195997412 | - | 0.007025976 | 0.99297404 |
Top |
Fusion Genomic Features for GRB2-PCYT1A |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for GRB2-PCYT1A |
Go to FGviewer for the breakpoints of chr17:73389632-chr3:195997412 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
GRB2 | . |
FUNCTION: Adapter protein that provides a critical link between cell surface growth factor receptors and the Ras signaling pathway. {ECO:0000269|PubMed:1322798, ECO:0000269|PubMed:19815557}.; FUNCTION: [Isoform 2]: Does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death. {ECO:0000269|PubMed:8178156}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 168_169 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 196_200 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 84_92 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 168_169 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 196_200 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 84_92 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 168_169 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 196_200 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 84_92 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 168_169 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 196_200 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 84_92 | 0 | 368.0 | Nucleotide binding | CTP | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 228_287 | 0 | 368.0 | Region | Amphipathic | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 256_288 | 0 | 368.0 | Region | 3 X 11 AA approximate tandem repeats%3B mediates binding and activation by anionic lipid vesicles | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 319_348 | 0 | 368.0 | Region | Note=3 X repeats | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 228_287 | 0 | 368.0 | Region | Amphipathic | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 256_288 | 0 | 368.0 | Region | 3 X 11 AA approximate tandem repeats%3B mediates binding and activation by anionic lipid vesicles | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 319_348 | 0 | 368.0 | Region | Note=3 X repeats | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 228_287 | 0 | 368.0 | Region | Amphipathic | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 256_288 | 0 | 368.0 | Region | 3 X 11 AA approximate tandem repeats%3B mediates binding and activation by anionic lipid vesicles | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 319_348 | 0 | 368.0 | Region | Note=3 X repeats | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 228_287 | 0 | 368.0 | Region | Amphipathic | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 256_288 | 0 | 368.0 | Region | 3 X 11 AA approximate tandem repeats%3B mediates binding and activation by anionic lipid vesicles | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 319_348 | 0 | 368.0 | Region | Note=3 X repeats | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 319_324 | 0 | 368.0 | Repeat | Note=1 | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 329_333 | 0 | 368.0 | Repeat | Note=2%3B approximate | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000292823 | 1 | 10 | 343_348 | 0 | 368.0 | Repeat | Note=3 | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 319_324 | 0 | 368.0 | Repeat | Note=1 | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 329_333 | 0 | 368.0 | Repeat | Note=2%3B approximate | |
Tgene | PCYT1A | chr17:73389631 | chr3:195997412 | ENST00000431016 | 0 | 9 | 343_348 | 0 | 368.0 | Repeat | Note=3 | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 319_324 | 0 | 368.0 | Repeat | Note=1 | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 329_333 | 0 | 368.0 | Repeat | Note=2%3B approximate | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000292823 | 1 | 10 | 343_348 | 0 | 368.0 | Repeat | Note=3 | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 319_324 | 0 | 368.0 | Repeat | Note=1 | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 329_333 | 0 | 368.0 | Repeat | Note=2%3B approximate | |
Tgene | PCYT1A | chr17:73389632 | chr3:195997412 | ENST00000431016 | 0 | 9 | 343_348 | 0 | 368.0 | Repeat | Note=3 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000316615 | - | 2 | 5 | 156_215 | 26.0 | 177.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000316615 | - | 2 | 5 | 1_58 | 26.0 | 177.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000316615 | - | 2 | 5 | 60_152 | 26.0 | 177.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000316804 | - | 2 | 6 | 156_215 | 26.0 | 218.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000316804 | - | 2 | 6 | 1_58 | 26.0 | 218.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000316804 | - | 2 | 6 | 60_152 | 26.0 | 218.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392562 | - | 2 | 6 | 156_215 | 26.0 | 218.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392562 | - | 2 | 6 | 1_58 | 26.0 | 218.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392562 | - | 2 | 6 | 60_152 | 26.0 | 218.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392563 | - | 1 | 4 | 156_215 | 26.0 | 177.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392563 | - | 1 | 4 | 1_58 | 26.0 | 177.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392563 | - | 1 | 4 | 60_152 | 26.0 | 177.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392564 | - | 1 | 5 | 156_215 | 26.0 | 218.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392564 | - | 1 | 5 | 1_58 | 26.0 | 218.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389631 | chr3:195997412 | ENST00000392564 | - | 1 | 5 | 60_152 | 26.0 | 218.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000316615 | - | 2 | 5 | 156_215 | 26.0 | 177.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000316615 | - | 2 | 5 | 1_58 | 26.0 | 177.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000316615 | - | 2 | 5 | 60_152 | 26.0 | 177.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000316804 | - | 2 | 6 | 156_215 | 26.0 | 218.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000316804 | - | 2 | 6 | 1_58 | 26.0 | 218.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000316804 | - | 2 | 6 | 60_152 | 26.0 | 218.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392562 | - | 2 | 6 | 156_215 | 26.0 | 218.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392562 | - | 2 | 6 | 1_58 | 26.0 | 218.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392562 | - | 2 | 6 | 60_152 | 26.0 | 218.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392563 | - | 1 | 4 | 156_215 | 26.0 | 177.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392563 | - | 1 | 4 | 1_58 | 26.0 | 177.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392563 | - | 1 | 4 | 60_152 | 26.0 | 177.0 | Domain | SH2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392564 | - | 1 | 5 | 156_215 | 26.0 | 218.0 | Domain | SH3 2 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392564 | - | 1 | 5 | 1_58 | 26.0 | 218.0 | Domain | SH3 1 |
Hgene | GRB2 | chr17:73389632 | chr3:195997412 | ENST00000392564 | - | 1 | 5 | 60_152 | 26.0 | 218.0 | Domain | SH2 |
Top |
Fusion Gene Sequence for GRB2-PCYT1A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000392563_ENST00000419333_TCGA-46-6025-01A_GRB2_chr17_73389632_-_PCYT1A_chr3_195997412_length(transcript)=1431nt_BP=106nt GGCTGCTGAGCACTGAGCAGCGCTCAGAATGGAAGCCATCGCCAAATATGACTTCAAAGCTACTGCAGACGACGAGCTGAGCTTCAAAAG GGGGGACATCCTCAAGTTAAAAGAAGATGGATGCACAGTGTTCAGCCAAGGTCAATGCAAGGAAGAGGAGAAAAGAGGCGCCCGGACCCA ACGGGGCAACAGAAGAAGATGGGGTTCCTTCCAAAGTGCAGCGCTGTGCAGTGGGCTTACGGCAACCAGCTCCTTTTTCTGATGAAATTG AAGTTGACTTTAGTAAGCCCTATGTCAGGGTAACTATGGAAGAAGCCAGCAGAGGAACTCCTTGTGAGCGACCTGTGAGAGTTTATGCCG ATGGAATATTTGACTTATTTCACTCTGGTCACGCCCGAGCTCTGATGCAAGCGAAGAACCTTTTCCCTAATACGTACCTCATTGTGGGAG TTTGCAGTGATGAGCTCACACACAACTTCAAAGGCTTCACGGTGATGAACGAGAATGAGCGCTATGACGCAGTCCAGCACTGCCGCTACG TGGATGAGGTGGTGAGGAATGCGCCCTGGACGCTGACACCCGAGTTCCTGGCCGAACACCGGATTGATTTTGTAGCCCATGATGATATTC CTTATTCATCTGCTGGCAGTGATGATGTTTATAAGCACATCAAGGAGGCAGGCATGTTTGCTCCAACACAGAGGACAGAAGGTATCTCCA CATCAGACATCATCACCCGAATTGTGCGGGATTATGATGTGTATGCGAGGCGGAACCTGCAGAGGGGCTACACAGCAAAGGAGCTCAATG TCAGCTTTATCAACGAGAAGAAATACCACTTGCAGGAGAGGGTTGACAAAGTAAAGAAGAAAGTGAAAGATGTGGAGGAAAAGTCAAAAG AATTTGTTCAGAAGGTGGAGGAAAAAAGCATTGACCTCATTCAGAAGTGGGAGGAGAAGTCCCGAGAATTCATTGGAAGTTTTCTGGAAA TGTTTGGTCCGGAAGGAGCACTGAAACATATGCTGAAAGAGGGGAAGGGCCGGATGCTGCAGGCCATCAGCCCGAAGCAGAGCCCCAGCA GCAGCCCTACTCGCGAGCGCTCCCCCTCCCCCTCTTTCCGATGGCCCTTCTCCGGCAAGACTTCCCCACCTTGCTCCCCAGCAAATCTCT CCAGGCACAAGGCTGCAGCCTATGATATCAGGTATAGTTACCTGGAACAGAGCAAATTTGGCTCCCATGTTCTGCTCACCCAGGTGTAGC CTGGCTTGACGGGAAATGATGCCCAGGGTCCAGAGAGCCAGCAGTGTGGACACGCCAAGGAAAGTGTTGATCCATAGAGCTGTGCTCCCC >In-frame_ENST00000392563_ENST00000419333_TCGA-46-6025-01A_GRB2_chr17_73389632_-_PCYT1A_chr3_195997412_length(amino acids)=380AA_start in transcript=116_stop in transcript=1258 MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDEIEVDFSKPYVRVTMEEASRGTPCERPVRVYADGIFDLFHS GHARALMQAKNLFPNTYLIVGVCSDELTHNFKGFTVMNENERYDAVQHCRYVDEVVRNAPWTLTPEFLAEHRIDFVAHDDIPYSSAGSDD VYKHIKEAGMFAPTQRTEGISTSDIITRIVRDYDVYARRNLQRGYTAKELNVSFINEKKYHLQERVDKVKKKVKDVEEKSKEFVQKVEEK SIDLIQKWEEKSREFIGSFLEMFGPEGALKHMLKEGKGRMLQAISPKQSPSSSPTRERSPSPSFRWPFSGKTSPPCSPANLSRHKAAAYD -------------------------------------------------------------- >In-frame_ENST00000392564_ENST00000419333_TCGA-46-6025-01A_GRB2_chr17_73389632_-_PCYT1A_chr3_195997412_length(transcript)=1639nt_BP=314nt GAGCCAGGGGGCGTGGGGGCTGGGACAGCAGGCCGATTGGCAGGGCGGGGTTGCCTTCAATCCTGGCCACTGCTCTTAATCGTCCCTCTC CTGCTTCAGGGTGGCATTGTGTGTCCCAGAGTGCCGGAGCGAGTCCCAGAAGAGAGGCGAGGCTAAGCCCAGAGCGCTGGGTTGCTTCAG CAGGGAAGACTCCCTTCCCCCTGCTTCAGGCTGCTGAGCACTGAGCAGCGCTCAGAATGGAAGCCATCGCCAAATATGACTTCAAAGCTA CTGCAGACGACGAGCTGAGCTTCAAAAGGGGGGACATCCTCAAGTTAAAAGAAGATGGATGCACAGTGTTCAGCCAAGGTCAATGCAAGG AAGAGGAGAAAAGAGGCGCCCGGACCCAACGGGGCAACAGAAGAAGATGGGGTTCCTTCCAAAGTGCAGCGCTGTGCAGTGGGCTTACGG CAACCAGCTCCTTTTTCTGATGAAATTGAAGTTGACTTTAGTAAGCCCTATGTCAGGGTAACTATGGAAGAAGCCAGCAGAGGAACTCCT TGTGAGCGACCTGTGAGAGTTTATGCCGATGGAATATTTGACTTATTTCACTCTGGTCACGCCCGAGCTCTGATGCAAGCGAAGAACCTT TTCCCTAATACGTACCTCATTGTGGGAGTTTGCAGTGATGAGCTCACACACAACTTCAAAGGCTTCACGGTGATGAACGAGAATGAGCGC TATGACGCAGTCCAGCACTGCCGCTACGTGGATGAGGTGGTGAGGAATGCGCCCTGGACGCTGACACCCGAGTTCCTGGCCGAACACCGG ATTGATTTTGTAGCCCATGATGATATTCCTTATTCATCTGCTGGCAGTGATGATGTTTATAAGCACATCAAGGAGGCAGGCATGTTTGCT CCAACACAGAGGACAGAAGGTATCTCCACATCAGACATCATCACCCGAATTGTGCGGGATTATGATGTGTATGCGAGGCGGAACCTGCAG AGGGGCTACACAGCAAAGGAGCTCAATGTCAGCTTTATCAACGAGAAGAAATACCACTTGCAGGAGAGGGTTGACAAAGTAAAGAAGAAA GTGAAAGATGTGGAGGAAAAGTCAAAAGAATTTGTTCAGAAGGTGGAGGAAAAAAGCATTGACCTCATTCAGAAGTGGGAGGAGAAGTCC CGAGAATTCATTGGAAGTTTTCTGGAAATGTTTGGTCCGGAAGGAGCACTGAAACATATGCTGAAAGAGGGGAAGGGCCGGATGCTGCAG GCCATCAGCCCGAAGCAGAGCCCCAGCAGCAGCCCTACTCGCGAGCGCTCCCCCTCCCCCTCTTTCCGATGGCCCTTCTCCGGCAAGACT TCCCCACCTTGCTCCCCAGCAAATCTCTCCAGGCACAAGGCTGCAGCCTATGATATCAGGTATAGTTACCTGGAACAGAGCAAATTTGGC TCCCATGTTCTGCTCACCCAGGTGTAGCCTGGCTTGACGGGAAATGATGCCCAGGGTCCAGAGAGCCAGCAGTGTGGACACGCCAAGGAA AGTGTTGATCCATAGAGCTGTGCTCCCCTCAGAAATCTGGTGGCAACAGAAAGTAGTCAGTGAGGCAGGCAAGCTCTCTCTCTCTCTCTC >In-frame_ENST00000392564_ENST00000419333_TCGA-46-6025-01A_GRB2_chr17_73389632_-_PCYT1A_chr3_195997412_length(amino acids)=380AA_start in transcript=324_stop in transcript=1466 MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDEIEVDFSKPYVRVTMEEASRGTPCERPVRVYADGIFDLFHS GHARALMQAKNLFPNTYLIVGVCSDELTHNFKGFTVMNENERYDAVQHCRYVDEVVRNAPWTLTPEFLAEHRIDFVAHDDIPYSSAGSDD VYKHIKEAGMFAPTQRTEGISTSDIITRIVRDYDVYARRNLQRGYTAKELNVSFINEKKYHLQERVDKVKKKVKDVEEKSKEFVQKVEEK SIDLIQKWEEKSREFIGSFLEMFGPEGALKHMLKEGKGRMLQAISPKQSPSSSPTRERSPSPSFRWPFSGKTSPPCSPANLSRHKAAAYD -------------------------------------------------------------- >In-frame_ENST00000578961_ENST00000419333_TCGA-46-6025-01A_GRB2_chr17_73389632_-_PCYT1A_chr3_195997412_length(transcript)=1578nt_BP=253nt CCTGGCCACTGCTCTTAATCGTCCCTCTCCTGCTTCAGGGTGGCATTGTGTGTCCCAGAGTGCCGGAGCGAGTCCCAGAAGAGAGGCGAG GCTAAGCCCAGAGCGCTGGGTTGCTTCAGCAGGGAAGACTCCCTTCCCCCTGCTTCAGGCTGCTGAGCACTGAGCAGCGCTCAGAATGGA AGCCATCGCCAAATATGACTTCAAAGCTACTGCAGACGACGAGCTGAGCTTCAAAAGGGGGGACATCCTCAAGTTAAAAGAAGATGGATG CACAGTGTTCAGCCAAGGTCAATGCAAGGAAGAGGAGAAAAGAGGCGCCCGGACCCAACGGGGCAACAGAAGAAGATGGGGTTCCTTCCA AAGTGCAGCGCTGTGCAGTGGGCTTACGGCAACCAGCTCCTTTTTCTGATGAAATTGAAGTTGACTTTAGTAAGCCCTATGTCAGGGTAA CTATGGAAGAAGCCAGCAGAGGAACTCCTTGTGAGCGACCTGTGAGAGTTTATGCCGATGGAATATTTGACTTATTTCACTCTGGTCACG CCCGAGCTCTGATGCAAGCGAAGAACCTTTTCCCTAATACGTACCTCATTGTGGGAGTTTGCAGTGATGAGCTCACACACAACTTCAAAG GCTTCACGGTGATGAACGAGAATGAGCGCTATGACGCAGTCCAGCACTGCCGCTACGTGGATGAGGTGGTGAGGAATGCGCCCTGGACGC TGACACCCGAGTTCCTGGCCGAACACCGGATTGATTTTGTAGCCCATGATGATATTCCTTATTCATCTGCTGGCAGTGATGATGTTTATA AGCACATCAAGGAGGCAGGCATGTTTGCTCCAACACAGAGGACAGAAGGTATCTCCACATCAGACATCATCACCCGAATTGTGCGGGATT ATGATGTGTATGCGAGGCGGAACCTGCAGAGGGGCTACACAGCAAAGGAGCTCAATGTCAGCTTTATCAACGAGAAGAAATACCACTTGC AGGAGAGGGTTGACAAAGTAAAGAAGAAAGTGAAAGATGTGGAGGAAAAGTCAAAAGAATTTGTTCAGAAGGTGGAGGAAAAAAGCATTG ACCTCATTCAGAAGTGGGAGGAGAAGTCCCGAGAATTCATTGGAAGTTTTCTGGAAATGTTTGGTCCGGAAGGAGCACTGAAACATATGC TGAAAGAGGGGAAGGGCCGGATGCTGCAGGCCATCAGCCCGAAGCAGAGCCCCAGCAGCAGCCCTACTCGCGAGCGCTCCCCCTCCCCCT CTTTCCGATGGCCCTTCTCCGGCAAGACTTCCCCACCTTGCTCCCCAGCAAATCTCTCCAGGCACAAGGCTGCAGCCTATGATATCAGGT ATAGTTACCTGGAACAGAGCAAATTTGGCTCCCATGTTCTGCTCACCCAGGTGTAGCCTGGCTTGACGGGAAATGATGCCCAGGGTCCAG AGAGCCAGCAGTGTGGACACGCCAAGGAAAGTGTTGATCCATAGAGCTGTGCTCCCCTCAGAAATCTGGTGGCAACAGAAAGTAGTCAGT >In-frame_ENST00000578961_ENST00000419333_TCGA-46-6025-01A_GRB2_chr17_73389632_-_PCYT1A_chr3_195997412_length(amino acids)=380AA_start in transcript=263_stop in transcript=1405 MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDEIEVDFSKPYVRVTMEEASRGTPCERPVRVYADGIFDLFHS GHARALMQAKNLFPNTYLIVGVCSDELTHNFKGFTVMNENERYDAVQHCRYVDEVVRNAPWTLTPEFLAEHRIDFVAHDDIPYSSAGSDD VYKHIKEAGMFAPTQRTEGISTSDIITRIVRDYDVYARRNLQRGYTAKELNVSFINEKKYHLQERVDKVKKKVKDVEEKSKEFVQKVEEK SIDLIQKWEEKSREFIGSFLEMFGPEGALKHMLKEGKGRMLQAISPKQSPSSSPTRERSPSPSFRWPFSGKTSPPCSPANLSRHKAAAYD -------------------------------------------------------------- >In-frame_ENST00000392563_ENST00000419333_TCGA-46-6025_GRB2_chr17_73389631_-_PCYT1A_chr3_195997412_length(transcript)=1431nt_BP=106nt GGCTGCTGAGCACTGAGCAGCGCTCAGAATGGAAGCCATCGCCAAATATGACTTCAAAGCTACTGCAGACGACGAGCTGAGCTTCAAAAG GGGGGACATCCTCAAGTTAAAAGAAGATGGATGCACAGTGTTCAGCCAAGGTCAATGCAAGGAAGAGGAGAAAAGAGGCGCCCGGACCCA ACGGGGCAACAGAAGAAGATGGGGTTCCTTCCAAAGTGCAGCGCTGTGCAGTGGGCTTACGGCAACCAGCTCCTTTTTCTGATGAAATTG AAGTTGACTTTAGTAAGCCCTATGTCAGGGTAACTATGGAAGAAGCCAGCAGAGGAACTCCTTGTGAGCGACCTGTGAGAGTTTATGCCG ATGGAATATTTGACTTATTTCACTCTGGTCACGCCCGAGCTCTGATGCAAGCGAAGAACCTTTTCCCTAATACGTACCTCATTGTGGGAG TTTGCAGTGATGAGCTCACACACAACTTCAAAGGCTTCACGGTGATGAACGAGAATGAGCGCTATGACGCAGTCCAGCACTGCCGCTACG TGGATGAGGTGGTGAGGAATGCGCCCTGGACGCTGACACCCGAGTTCCTGGCCGAACACCGGATTGATTTTGTAGCCCATGATGATATTC CTTATTCATCTGCTGGCAGTGATGATGTTTATAAGCACATCAAGGAGGCAGGCATGTTTGCTCCAACACAGAGGACAGAAGGTATCTCCA CATCAGACATCATCACCCGAATTGTGCGGGATTATGATGTGTATGCGAGGCGGAACCTGCAGAGGGGCTACACAGCAAAGGAGCTCAATG TCAGCTTTATCAACGAGAAGAAATACCACTTGCAGGAGAGGGTTGACAAAGTAAAGAAGAAAGTGAAAGATGTGGAGGAAAAGTCAAAAG AATTTGTTCAGAAGGTGGAGGAAAAAAGCATTGACCTCATTCAGAAGTGGGAGGAGAAGTCCCGAGAATTCATTGGAAGTTTTCTGGAAA TGTTTGGTCCGGAAGGAGCACTGAAACATATGCTGAAAGAGGGGAAGGGCCGGATGCTGCAGGCCATCAGCCCGAAGCAGAGCCCCAGCA GCAGCCCTACTCGCGAGCGCTCCCCCTCCCCCTCTTTCCGATGGCCCTTCTCCGGCAAGACTTCCCCACCTTGCTCCCCAGCAAATCTCT CCAGGCACAAGGCTGCAGCCTATGATATCAGGTATAGTTACCTGGAACAGAGCAAATTTGGCTCCCATGTTCTGCTCACCCAGGTGTAGC CTGGCTTGACGGGAAATGATGCCCAGGGTCCAGAGAGCCAGCAGTGTGGACACGCCAAGGAAAGTGTTGATCCATAGAGCTGTGCTCCCC >In-frame_ENST00000392563_ENST00000419333_TCGA-46-6025_GRB2_chr17_73389631_-_PCYT1A_chr3_195997412_length(amino acids)=380AA_start in transcript=116_stop in transcript=1258 MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDEIEVDFSKPYVRVTMEEASRGTPCERPVRVYADGIFDLFHS GHARALMQAKNLFPNTYLIVGVCSDELTHNFKGFTVMNENERYDAVQHCRYVDEVVRNAPWTLTPEFLAEHRIDFVAHDDIPYSSAGSDD VYKHIKEAGMFAPTQRTEGISTSDIITRIVRDYDVYARRNLQRGYTAKELNVSFINEKKYHLQERVDKVKKKVKDVEEKSKEFVQKVEEK SIDLIQKWEEKSREFIGSFLEMFGPEGALKHMLKEGKGRMLQAISPKQSPSSSPTRERSPSPSFRWPFSGKTSPPCSPANLSRHKAAAYD -------------------------------------------------------------- >In-frame_ENST00000392564_ENST00000419333_TCGA-46-6025_GRB2_chr17_73389631_-_PCYT1A_chr3_195997412_length(transcript)=1639nt_BP=314nt GAGCCAGGGGGCGTGGGGGCTGGGACAGCAGGCCGATTGGCAGGGCGGGGTTGCCTTCAATCCTGGCCACTGCTCTTAATCGTCCCTCTC CTGCTTCAGGGTGGCATTGTGTGTCCCAGAGTGCCGGAGCGAGTCCCAGAAGAGAGGCGAGGCTAAGCCCAGAGCGCTGGGTTGCTTCAG CAGGGAAGACTCCCTTCCCCCTGCTTCAGGCTGCTGAGCACTGAGCAGCGCTCAGAATGGAAGCCATCGCCAAATATGACTTCAAAGCTA CTGCAGACGACGAGCTGAGCTTCAAAAGGGGGGACATCCTCAAGTTAAAAGAAGATGGATGCACAGTGTTCAGCCAAGGTCAATGCAAGG AAGAGGAGAAAAGAGGCGCCCGGACCCAACGGGGCAACAGAAGAAGATGGGGTTCCTTCCAAAGTGCAGCGCTGTGCAGTGGGCTTACGG CAACCAGCTCCTTTTTCTGATGAAATTGAAGTTGACTTTAGTAAGCCCTATGTCAGGGTAACTATGGAAGAAGCCAGCAGAGGAACTCCT TGTGAGCGACCTGTGAGAGTTTATGCCGATGGAATATTTGACTTATTTCACTCTGGTCACGCCCGAGCTCTGATGCAAGCGAAGAACCTT TTCCCTAATACGTACCTCATTGTGGGAGTTTGCAGTGATGAGCTCACACACAACTTCAAAGGCTTCACGGTGATGAACGAGAATGAGCGC TATGACGCAGTCCAGCACTGCCGCTACGTGGATGAGGTGGTGAGGAATGCGCCCTGGACGCTGACACCCGAGTTCCTGGCCGAACACCGG ATTGATTTTGTAGCCCATGATGATATTCCTTATTCATCTGCTGGCAGTGATGATGTTTATAAGCACATCAAGGAGGCAGGCATGTTTGCT CCAACACAGAGGACAGAAGGTATCTCCACATCAGACATCATCACCCGAATTGTGCGGGATTATGATGTGTATGCGAGGCGGAACCTGCAG AGGGGCTACACAGCAAAGGAGCTCAATGTCAGCTTTATCAACGAGAAGAAATACCACTTGCAGGAGAGGGTTGACAAAGTAAAGAAGAAA GTGAAAGATGTGGAGGAAAAGTCAAAAGAATTTGTTCAGAAGGTGGAGGAAAAAAGCATTGACCTCATTCAGAAGTGGGAGGAGAAGTCC CGAGAATTCATTGGAAGTTTTCTGGAAATGTTTGGTCCGGAAGGAGCACTGAAACATATGCTGAAAGAGGGGAAGGGCCGGATGCTGCAG GCCATCAGCCCGAAGCAGAGCCCCAGCAGCAGCCCTACTCGCGAGCGCTCCCCCTCCCCCTCTTTCCGATGGCCCTTCTCCGGCAAGACT TCCCCACCTTGCTCCCCAGCAAATCTCTCCAGGCACAAGGCTGCAGCCTATGATATCAGGTATAGTTACCTGGAACAGAGCAAATTTGGC TCCCATGTTCTGCTCACCCAGGTGTAGCCTGGCTTGACGGGAAATGATGCCCAGGGTCCAGAGAGCCAGCAGTGTGGACACGCCAAGGAA AGTGTTGATCCATAGAGCTGTGCTCCCCTCAGAAATCTGGTGGCAACAGAAAGTAGTCAGTGAGGCAGGCAAGCTCTCTCTCTCTCTCTC >In-frame_ENST00000392564_ENST00000419333_TCGA-46-6025_GRB2_chr17_73389631_-_PCYT1A_chr3_195997412_length(amino acids)=380AA_start in transcript=324_stop in transcript=1466 MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDEIEVDFSKPYVRVTMEEASRGTPCERPVRVYADGIFDLFHS GHARALMQAKNLFPNTYLIVGVCSDELTHNFKGFTVMNENERYDAVQHCRYVDEVVRNAPWTLTPEFLAEHRIDFVAHDDIPYSSAGSDD VYKHIKEAGMFAPTQRTEGISTSDIITRIVRDYDVYARRNLQRGYTAKELNVSFINEKKYHLQERVDKVKKKVKDVEEKSKEFVQKVEEK SIDLIQKWEEKSREFIGSFLEMFGPEGALKHMLKEGKGRMLQAISPKQSPSSSPTRERSPSPSFRWPFSGKTSPPCSPANLSRHKAAAYD -------------------------------------------------------------- >In-frame_ENST00000578961_ENST00000419333_TCGA-46-6025_GRB2_chr17_73389631_-_PCYT1A_chr3_195997412_length(transcript)=1578nt_BP=253nt CCTGGCCACTGCTCTTAATCGTCCCTCTCCTGCTTCAGGGTGGCATTGTGTGTCCCAGAGTGCCGGAGCGAGTCCCAGAAGAGAGGCGAG GCTAAGCCCAGAGCGCTGGGTTGCTTCAGCAGGGAAGACTCCCTTCCCCCTGCTTCAGGCTGCTGAGCACTGAGCAGCGCTCAGAATGGA AGCCATCGCCAAATATGACTTCAAAGCTACTGCAGACGACGAGCTGAGCTTCAAAAGGGGGGACATCCTCAAGTTAAAAGAAGATGGATG CACAGTGTTCAGCCAAGGTCAATGCAAGGAAGAGGAGAAAAGAGGCGCCCGGACCCAACGGGGCAACAGAAGAAGATGGGGTTCCTTCCA AAGTGCAGCGCTGTGCAGTGGGCTTACGGCAACCAGCTCCTTTTTCTGATGAAATTGAAGTTGACTTTAGTAAGCCCTATGTCAGGGTAA CTATGGAAGAAGCCAGCAGAGGAACTCCTTGTGAGCGACCTGTGAGAGTTTATGCCGATGGAATATTTGACTTATTTCACTCTGGTCACG CCCGAGCTCTGATGCAAGCGAAGAACCTTTTCCCTAATACGTACCTCATTGTGGGAGTTTGCAGTGATGAGCTCACACACAACTTCAAAG GCTTCACGGTGATGAACGAGAATGAGCGCTATGACGCAGTCCAGCACTGCCGCTACGTGGATGAGGTGGTGAGGAATGCGCCCTGGACGC TGACACCCGAGTTCCTGGCCGAACACCGGATTGATTTTGTAGCCCATGATGATATTCCTTATTCATCTGCTGGCAGTGATGATGTTTATA AGCACATCAAGGAGGCAGGCATGTTTGCTCCAACACAGAGGACAGAAGGTATCTCCACATCAGACATCATCACCCGAATTGTGCGGGATT ATGATGTGTATGCGAGGCGGAACCTGCAGAGGGGCTACACAGCAAAGGAGCTCAATGTCAGCTTTATCAACGAGAAGAAATACCACTTGC AGGAGAGGGTTGACAAAGTAAAGAAGAAAGTGAAAGATGTGGAGGAAAAGTCAAAAGAATTTGTTCAGAAGGTGGAGGAAAAAAGCATTG ACCTCATTCAGAAGTGGGAGGAGAAGTCCCGAGAATTCATTGGAAGTTTTCTGGAAATGTTTGGTCCGGAAGGAGCACTGAAACATATGC TGAAAGAGGGGAAGGGCCGGATGCTGCAGGCCATCAGCCCGAAGCAGAGCCCCAGCAGCAGCCCTACTCGCGAGCGCTCCCCCTCCCCCT CTTTCCGATGGCCCTTCTCCGGCAAGACTTCCCCACCTTGCTCCCCAGCAAATCTCTCCAGGCACAAGGCTGCAGCCTATGATATCAGGT ATAGTTACCTGGAACAGAGCAAATTTGGCTCCCATGTTCTGCTCACCCAGGTGTAGCCTGGCTTGACGGGAAATGATGCCCAGGGTCCAG AGAGCCAGCAGTGTGGACACGCCAAGGAAAGTGTTGATCCATAGAGCTGTGCTCCCCTCAGAAATCTGGTGGCAACAGAAAGTAGTCAGT >In-frame_ENST00000578961_ENST00000419333_TCGA-46-6025_GRB2_chr17_73389631_-_PCYT1A_chr3_195997412_length(amino acids)=380AA_start in transcript=263_stop in transcript=1405 MDAQCSAKVNARKRRKEAPGPNGATEEDGVPSKVQRCAVGLRQPAPFSDEIEVDFSKPYVRVTMEEASRGTPCERPVRVYADGIFDLFHS GHARALMQAKNLFPNTYLIVGVCSDELTHNFKGFTVMNENERYDAVQHCRYVDEVVRNAPWTLTPEFLAEHRIDFVAHDDIPYSSAGSDD VYKHIKEAGMFAPTQRTEGISTSDIITRIVRDYDVYARRNLQRGYTAKELNVSFINEKKYHLQERVDKVKKKVKDVEEKSKEFVQKVEEK SIDLIQKWEEKSREFIGSFLEMFGPEGALKHMLKEGKGRMLQAISPKQSPSSSPTRERSPSPSFRWPFSGKTSPPCSPANLSRHKAAAYD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for GRB2-PCYT1A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for GRB2-PCYT1A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | GRB2 | P62993 | DB00061 | Pegademase | Binder | Biotech | Approved |
Hgene | GRB2 | P62993 | DB00061 | Pegademase | Binder | Biotech | Approved |
Top |
Related Diseases for GRB2-PCYT1A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GRB2 | C0036341 | Schizophrenia | 2 | PSYGENET |
Tgene | PCYT1A | C1837073 | Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | PCYT1A | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | PCYT1A | C0038219 | Status Dysraphicus | 1 | CTD_human |
Tgene | PCYT1A | C0080178 | Spina Bifida | 1 | CTD_human |
Tgene | PCYT1A | C0266508 | Rachischisis | 1 | CTD_human |
Tgene | PCYT1A | C0339527 | Leber Congenital Amaurosis | 1 | ORPHANET |
Tgene | PCYT1A | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | PCYT1A | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | PCYT1A | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | PCYT1A | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | PCYT1A | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |